Fig. 2From: Prognostic value of performance status in metastatic renal cell carcinoma patients receiving tyrosine kinase inhibitors: a systematic review and meta-analysisForest plot showing the effects of PS on a overall survival b progression-free survival in mRCC patients receiving TKIsBack to article page